{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:37:28Z","timestamp":1793633848497,"version":"4.5.1"},"reference-count":193,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.phymed.2024.155379","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T17:37:18Z","timestamp":1705599438000},"page":"155379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy"],"prefix":"10.1016","volume":"128","author":[{"given":"Chakrabhavi Dhananjaya","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8314-9227","authenticated-orcid":false,"given":"Muthu K","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddegowda Gopalapura Shivanne","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunachalam","family":"Chinnathambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchugarakoppal S.","family":"Rangappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.155379_bib0001","first-page":"363","article-title":"Anticancer potential of curcumin: preclinical and clinical studies","volume":"23","author":"Aggarwal","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101756","article-title":"Augmented antitumor effects of erlotinib and cabozantinib on A549 non-small cell lung cancer: in vitro and in vivo studies","volume":"31","author":"Alhazzani","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.phymed.2024.155379_bib0003","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.biopha.2018.07.055","article-title":"Phytochemicals, withaferin A and carnosol, overcome pancreatic cancer stem cells as c-Met inhibitors","volume":"106","author":"Aliebrahimi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2024.155379_bib0004","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41419-023-06246-5","article-title":"A novel c-Met\/TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation","volume":"14","author":"An","year":"2023","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2024.155379_bib0005","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/med.21948","article-title":"Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds","volume":"43","author":"Ang","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phymed.2024.155379_bib0006","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2174\/138161213804547312","article-title":"Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer","volume":"19","author":"Avan","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phymed.2024.155379_bib0007","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1200\/JCO.2015.63.4600","article-title":"MET Exon 14 mutations in non-small-cell lung cancer are associated with advanced age and stage-dependent MET genomic amplification and c-Met overexpression","volume":"34","author":"Awad","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2024.155379_bib0008","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.eururo.2014.02.013","article-title":"Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort","volume":"67","author":"Basch","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.phymed.2024.155379_bib0009","doi-asserted-by":"crossref","first-page":"20932","DOI":"10.1073\/pnas.0710370104","article-title":"MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib","volume":"104","author":"Bean","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phymed.2024.155379_bib0010","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/sj.onc.1209227","article-title":"The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF\/Met signaling in immortalized and tumorigenic breast epithelial cells","volume":"25","author":"Bigelow","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155379_bib0011","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrm1261","article-title":"Met, metastasis, motility and more","volume":"4","author":"Birchmeier","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phymed.2024.155379_bib0012","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/cancers6031736","article-title":"The c-Met inhibitor MSC2156119J effectively inhibits tumor growth in liver cancer models","volume":"6","author":"Bladt","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.phymed.2024.155379_bib0013","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.1840190115","article-title":"c-met mRNA overexpression in human hepatocellular carcinoma","volume":"19","author":"Boix","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2024.155379_bib0014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12885-015-1064-9","article-title":"Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model","volume":"15","author":"Brandes","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0015","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the Human Development Index (2008-2030): a population-based study","volume":"13","author":"Bray","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phymed.2024.155379_bib0016","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12943-015-0367-4","article-title":"Quercetin inhibits HGF\/c-Met signaling and HGF-stimulated melanoma cell migration and invasion","volume":"14","author":"Cao","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0017","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/PPO.0000000000000619","article-title":"c-Met signaling as a therapeutic target in head and neck cancer","volume":"28","author":"Centuori","year":"2022","journal-title":"Cancer J."},{"key":"10.1016\/j.phymed.2024.155379_bib0018","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201409","article-title":"MET\u220614 promotes a ligand-dependent, AKT-driven invasive growth","volume":"5","author":"Cerqua","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.phymed.2024.155379_bib0019","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.apsb.2019.03.001","article-title":"Targeting slug-mediated non-canonical activation of c-Met to overcome chemo-resistance in metastatic ovarian cancer cells","volume":"9","author":"Chang","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2024.155379_bib0020","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1021\/acs.molpharmaceut.9b00428","article-title":"Celastrol-loaded galactosylated liposomes effectively inhibit AKT\/c-Met-triggered rapid hepatocarcinogenesis in mice","volume":"17","author":"Chen","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phymed.2024.155379_bib0021","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4132\/KoreanJPathol.2012.46.6.515","article-title":"Expression of c-Met is different along the location and associated with lymph node metastasis of head and neck carcinoma","volume":"46","author":"Choe","year":"2012","journal-title":"Korean J. Pathol."},{"key":"10.1016\/j.phymed.2024.155379_bib0022","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41416-023-02264-4","article-title":"Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer","volume":"128","author":"Choi","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ctrv.2016.07.003","article-title":"The prospect of precision therapy for renal cell carcinoma","volume":"49","author":"Ciccarese","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phymed.2024.155379_bib0024","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phymed.2024.155379_bib0025","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrd2530","article-title":"Drug development of MET inhibitors: targeting oncogene addiction and expedience","volume":"7","author":"Comoglio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2024.155379_bib0026","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1172\/JCI0215392","article-title":"Invasive growth: from development to metastasis","volume":"109","author":"Comoglio","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phymed.2024.155379_bib0027","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1038\/sj.onc.1207650","article-title":"Interplay between scatter factor receptors and B plexins controls invasive growth","volume":"23","author":"Conrotto","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155379_bib0028","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/311029a0","article-title":"Molecular cloning of a new transforming gene from a chemically transformed human cell line","volume":"311","author":"Cooper","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2024.155379_bib0029","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1158\/2159-8290.CD-13-0040","article-title":"Cell-autonomous and non-cell-autonomous mechanisms of HGF\/MET-driven resistance to targeted therapies: from basic research to a clinical perspective","volume":"3","author":"Corso","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phymed.2024.155379_bib0030","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/1097-0215(20000520)89:3<286::AID-IJC12>3.0.CO;2-U","article-title":"Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases","volume":"89","author":"Cortesina","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0031","doi-asserted-by":"crossref","first-page":"3431S","DOI":"10.1093\/jn\/134.12.3431S","article-title":"A review of the health effects of green tea catechins in in vivo animal models","volume":"134","author":"Crespy","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.phymed.2024.155379_bib0032","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1021\/jm2007613","article-title":"Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)","volume":"54","author":"Cui","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phymed.2024.155379_bib0033","doi-asserted-by":"crossref","first-page":"45525","DOI":"10.18632\/oncotarget.9997","article-title":"C-met inhibition blocks bone metastasis development induced by renal cancer stem cells","volume":"7","author":"D'Amico","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2024.155379_bib0034","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1158\/1078-0432.CCR-13-0839","article-title":"Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions","volume":"20","author":"Dai","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40169-019-0226-9","article-title":"Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma","volume":"8","author":"Daniel","year":"2019","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.phymed.2024.155379_bib0036","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI0215418","article-title":"Dysregulation of Met receptor tyrosine kinase activity in invasive tumors","volume":"109","author":"Danilkovitch-Miagkova","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phymed.2024.155379_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154914","article-title":"Quinacrine inhibits HIF-1\u03b1\/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells","volume":"117","author":"Das","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2024.155379_bib0038","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-08-0024","article-title":"Phase II trial of curcumin in patients with advanced pancreatic cancer","volume":"14","author":"Dhillon","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0039","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/sj.onc.1203455","article-title":"Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas","volume":"19","author":"Di Renzo","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155379_bib0040","first-page":"1129","article-title":"Expression of the Met\/hepatocyte growth factor receptor in human pancreatic cancer","volume":"55","author":"Di Renzo","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0041","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41591-019-0716-8","article-title":"Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration","volume":"26","author":"Drilon","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2024.155379_bib0042","first-page":"739","article-title":"The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells","volume":"49","author":"Duhon","year":"2010","journal-title":"Mol. Carcinogenes."},{"key":"10.1016\/j.phymed.2024.155379_bib0043","first-page":"5775","article-title":"Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer","volume":"54","author":"Ebert","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0044","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1055\/s-0030-1270724","article-title":"Oleocanthal as a c-Met inhibitor for the control of metastatic breast and prostate cancers","volume":"77","author":"Elnagar","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.phymed.2024.155379_bib0045","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1080\/01635581.2017.1367936","article-title":"Rutin as a novel c-Met inhibitory lead for the control of triple negative breast malignancies","volume":"69","author":"Elsayed","year":"2017","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0046","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1172\/JCI28656","article-title":"Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer","volume":"116","author":"Engelman","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phymed.2024.155379_bib0047","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.phymed.2024.155379_bib0048","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1101\/gad.284166.116","article-title":"HGF-independent regulation of MET and GAB1 by nonreceptor tyrosine kinase FER potentiates metastasis in ovarian cancer","volume":"30","author":"Fan","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.phymed.2024.155379_bib0049","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/cas.12891","article-title":"Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells","volume":"107","author":"Firtina Karagonlar","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phymed.2024.155379_bib0050","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/2159-8290.CD-15-0285","article-title":"Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors","volume":"5","author":"Frampton","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phymed.2024.155379_bib0051","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1038\/s41388-021-01863-w","article-title":"HGF\/c-MET pathway in cancer: from molecular characterization to clinical evidence","volume":"40","author":"Fu","year":"2021","journal-title":"Oncogene"},{"issue":"Suppl 1","key":"10.1016\/j.phymed.2024.155379_bib0052","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1007\/BF02439745","article-title":"Detection of MET oncogene\/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas","volume":"254","author":"Galeazzi","year":"1997","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.phymed.2024.155379_bib0053","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0021-9258(17)42099-0","article-title":"Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase","volume":"269","author":"Gandino","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2024.155379_bib0054","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3892\/or.2017.5347","article-title":"Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway","volume":"37","author":"Gao","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phymed.2024.155379_bib0055","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1038\/srep08021","article-title":"Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent antitumor compound against Hep G2 human hepatocellular carcinoma cells","volume":"5","author":"Garc\u00eda-Vilas","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2024.155379_bib0056","first-page":"1383","article-title":"Biosynthesis of the protein encoded by the c-met proto-oncogene","volume":"4","author":"Giordano","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155379_bib0057","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.155379_bib0058","article-title":"Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma","volume":"3","author":"Hagege","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.phymed.2024.155379_bib0059","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5687832","article-title":"Licochalcone A promotes the ubiquitination of c-Met to abrogate gefitinib resistance","volume":"2022","author":"Han","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phymed.2024.155379_bib0060","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.155379_bib0061","first-page":"1143","article-title":"Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization","volume":"78","author":"Hara","year":"1998","journal-title":"Lab. Investig."},{"key":"10.1016\/j.phymed.2024.155379_bib0062","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10555-022-10068-w","article-title":"Natural compounds targeting nuclear receptors for effective cancer therapy","volume":"42","author":"Hegde","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.phymed.2024.155379_bib0063","first-page":"6417","article-title":"Gene amplification in gastric and esophageal adenocarcinomas","volume":"50","author":"Houldsworth","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0064","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3892\/ol.2015.4063","article-title":"Curcumin mediates reversion of HGF-induced epithelial-mesenchymal transition via inhibition of c-Met expression in DU145 cells","volume":"11","author":"Hu","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phymed.2024.155379_bib0065","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1021\/jf2021489","article-title":"Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met\/Akt\/mTOR pathway in human breast cancer cells","volume":"59","author":"Hung","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phymed.2024.155379_bib0066","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10456-011-9243-z","article-title":"Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma","volume":"15","author":"Huynh","year":"2012","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phymed.2024.155379_bib0067","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/molecules25061320","article-title":"Evodiamine mitigates cellular growth and promotes apoptosis by targeting the c-met pathway in prostate cancer cells","volume":"25","author":"Hwang","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2024.155379_bib0068","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1002\/ijc.22178","article-title":"Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor\/c-Met pathway","volume":"119","author":"Ide","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0069","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1245\/s10434-007-9435-3","article-title":"The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor\/c-Met signaling","volume":"14","author":"Ide","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.phymed.2024.155379_bib0070","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/life13040948","article-title":"Phytochemicals as invaluable sources of potent antimicrobial agents to combat antibiotic resistance","volume":"13","author":"Jadimurthy","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.phymed.2024.155379_bib0071","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/0008-5472.CAN-04-4567","article-title":"Functional analysis of c-Met\/hepatocyte growth factor pathway in malignant pleural mesothelioma","volume":"66","author":"Jagadeeswaran","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0074","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1007\/s11033-013-2501-y","article-title":"Celastrol exerts synergistic effects with PHA-665752 and inhibits tumor growth of c-Met-deficient hepatocellular carcinoma in vivo","volume":"40","author":"Jiang","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.phymed.2024.155379_bib0075","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/mto.2016.18","article-title":"Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K\/Akt\/mTOR signaling pathways in lung cancer","volume":"3","author":"Jiao","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.phymed.2024.155379_bib0076","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/jcb.22888","article-title":"Integrin beta1 over-expression associates with resistance to tyrosine kinase inhibitor gefitinib in non-small cell lung cancer","volume":"111","author":"Ju","year":"2010","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.phymed.2024.155379_bib0077","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0145-2126(94)90003-5","article-title":"The Met\/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma","volume":"18","author":"Jucker","year":"1994","journal-title":"Leuk. Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0078","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neures.2009.06.016","article-title":"Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met\/HGF receptor contributes disease retardation of a transgenic mouse model of ALS","volume":"65","author":"Kadoyama","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0079","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.2147\/OTT.S189329","article-title":"Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case-control study","volume":"12","author":"Kalapanida","year":"2019","journal-title":"OncoTargets. Ther."},{"key":"10.1016\/j.phymed.2024.155379_bib0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2010.10.025","article-title":"Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer","volume":"303","author":"Kannaiyan","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.155379_bib0081","first-page":"495","article-title":"Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals","volume":"7","author":"Kato","year":"2017","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.phymed.2024.155379_bib0082","first-page":"627","article-title":"Increase in the circulating level of hepatocyte growth factor in pancreatic cancer patients","volume":"110","author":"Kemik","year":"2009","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.phymed.2024.155379_bib0083","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/ptr.5689","article-title":"Apigenin inhibits cancer stem cell-like phenotypes in human glioblastoma cells via suppression of c-Met signaling","volume":"30","author":"Kim","year":"2016","journal-title":"Phytother. Res. PTR"},{"key":"10.1016\/j.phymed.2024.155379_bib0084","doi-asserted-by":"crossref","first-page":"113120","DOI":"10.18632\/oncotarget.21303","article-title":"Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2024.155379_bib0085","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.3390\/ijms21114043","article-title":"Anticancer and antiangiogenic activities of novel \u03b1-mangostin glycosides in human hepatocellular carcinoma cells via downregulation of c-Met and HIF-1\u03b1","volume":"21","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2024.155379_bib0086","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1349-7006.2008.00828.x","article-title":"Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor\/c-Met system via hypoxia inducible factor-1 in pancreatic cancer","volume":"99","author":"Kitajima","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phymed.2024.155379_bib0087","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jnutbio.2010.09.005","article-title":"Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF\/c-Met","volume":"22","author":"Koh","year":"2011","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phymed.2024.155379_bib0088","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/s41467-020-15318-5","article-title":"A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma","volume":"11","author":"Kong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2024.155379_bib0089","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJMra044389","article-title":"Tyrosine kinases as targets for cancer therapy","volume":"353","author":"Krause","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2024.155379_bib0090","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1158\/1078-0432.CCR-09-0070","article-title":"Ethnic differences and functional analysis of MET mutations in lung cancer","volume":"15","author":"Krishnaswamy","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0091","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/ph16020160","article-title":"Withaferin A: a pleiotropic anticancer agent from the Indian medicinal plant Withania somnifera (L.) Dunal","volume":"16","author":"Kumar","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phymed.2024.155379_bib0092","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-291X(92)91548-5","article-title":"Frequent amplification of the c-met gene in scirrhous type stomach cancer","volume":"189","author":"Kuniyasu","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2024.155379_bib0093","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3858\/emm.2011.43.2.013","article-title":"Epigallocatechin-3-gallate inhibits paracrine and autocrine hepatocyte growth factor\/scatter factor-induced tumor cell migration and invasion","volume":"43","author":"Kwak","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phymed.2024.155379_bib0094","doi-asserted-by":"crossref","first-page":"3262S","DOI":"10.1093\/jn\/133.10.3262S","article-title":"Mechanisms of cancer prevention by tea constituents","volume":"133","author":"Lambert","year":"2003","journal-title":"J. Nutr."},{"key":"10.1016\/j.phymed.2024.155379_bib0095","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bbrc.2009.09.019","article-title":"Suppression of Met activation in human colon cancer cells treated with (-)-epigallocatechin-3-gallate: minor role of hydrogen peroxide","volume":"389","author":"Larsen","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2024.155379_bib0096","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.abb.2010.03.017","article-title":"Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells","volume":"501","author":"Larsen","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phymed.2024.155379_bib0097","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.canlet.2017.11.016","article-title":"Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis","volume":"414","author":"Lee","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.155379_bib0098","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1038\/sj.onc.1203874","article-title":"A novel germ line juxtamembrane Met mutation in human gastric cancer","volume":"19","author":"Lee","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155379_bib0099","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1158\/1078-0432.CCR-13-2636","article-title":"Cabozantinib and prostate cancer: inhibiting seed and disrupting soil?","volume":"20","author":"Lee","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106668","article-title":"Anlotinib combined with osimertinib reverses acquired osimertinib resistance in NSCLC by targeting the c-MET\/MYC\/AXL axis","volume":"188","author":"Lei","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0101","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ijc.20598","article-title":"C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2\/neu","volume":"113","author":"Lengyel","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0102","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18632\/oncotarget.22077","article-title":"Deguelin suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-c-Met pathway","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2024.155379_bib0103","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1172\/JCI118744","article-title":"Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors","volume":"97","author":"Liang","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phymed.2024.155379_bib0104","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2008.05.048","article-title":"Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells","volume":"271","author":"Lim","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.155379_bib0105","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1631\/jzus.B2000190","article-title":"Verticillin A inhibits colon cancer cell migration and invasion by targeting c-Met","volume":"21","author":"Liu","year":"2020","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.phymed.2024.155379_bib0106","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.18632\/oncotarget.3094","article-title":"Functional consequence of the MET-T1010I polymorphism in breast cancer","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2024.155379_bib0107","first-page":"7025","article-title":"Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion","volume":"62","author":"Lorenzato","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0108","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12967-015-0398-z","article-title":"Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer","volume":"13","author":"Lu","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phymed.2024.155379_bib0109","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1172\/JCI36640","article-title":"Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer","volume":"119","author":"Ma","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phymed.2024.155379_bib0110","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1158\/0008-5472.CAN-04-2650","article-title":"Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer","volume":"65","author":"Ma","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0111","first-page":"6272","article-title":"c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions","volume":"63","author":"Ma","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0112","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/gcc.20604","article-title":"Expression and mutational analysis of MET in human solid cancers","volume":"47","author":"Ma","year":"2008","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0113","first-page":"896","article-title":"ETS-1\/c-Met drives resistance to sorafenib in hepatocellular carcinoma","volume":"15","author":"Ma","year":"2023","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0114","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12967-015-0633-7","article-title":"Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer","volume":"13","author":"Madoz-G\u00farpide","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phymed.2024.155379_bib0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bmc.2015.11.038","article-title":"The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion","volume":"24","author":"Mady","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.phymed.2024.155379_bib0116","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1038\/s41467-019-13034-3","article-title":"EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogramming","volume":"10","author":"Meng","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2024.155379_bib0117","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.canlet.2013.03.008","article-title":"Alpha-lipoic acid-induced inhibition of proliferation and met phosphorylation in human non-small cell lung cancer cells","volume":"335","author":"Michikoshi","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.155379_bib0118","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.onc.1209057","article-title":"Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma","volume":"25","author":"Miller","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155379_bib0119","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/1078-0432.CCR-09-0109","article-title":"The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells","volume":"15","author":"Milligan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0120","doi-asserted-by":"crossref","first-page":"34296","DOI":"10.1074\/jbc.M114.601104","article-title":"Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo","volume":"289","author":"Mohan","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2024.155379_bib0121","article-title":"Paradoxical functions of long noncoding RNAs in modulating STAT3 signaling pathway in hepatocellular carcinoma","volume":"1876","author":"Mohan","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2024.155379_bib0122","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2021.04.029","article-title":"Inhibition of c-MET reverses radiation-induced malignant potential in pancreatic cancer","volume":"512","author":"Mori","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.155379_bib0123","doi-asserted-by":"crossref","first-page":"35","DOI":"10.21873\/anticanres.13924","article-title":"High expression of c-Met, PKC\u03bb and ALDH1A3 predicts a poor prognosis in late-stage breast cancer","volume":"40","author":"Motomura","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0124","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmedgenet-2015-103023","article-title":"A mutation of MET, encoding hepatocyte growth factor receptor, is associated with human DFNB97 hearing loss","volume":"52","author":"Mujtaba","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.phymed.2024.155379_bib0125","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1349-7006.2009.01343.x","article-title":"E7050: a dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models","volume":"101","author":"Nakagawa","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phymed.2024.155379_bib0126","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1349-7006.2007.00640.x","article-title":"Constitutive activation of c-Met is correlated with c-Met overexpression and dependent on cell-matrix adhesion in lung adenocarcinoma cell lines","volume":"99","author":"Nakamura","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phymed.2024.155379_bib0127","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1349-7006.2007.00493.x","article-title":"c-Met activation in lung adenocarcinoma tissues: an immunohistochemical analysis","volume":"98","author":"Nakamura","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phymed.2024.155379_bib0128","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cyto.2013.04.006","article-title":"Met\/HGF receptor activation is regulated by juxtamembrane Ser985 phosphorylation in hepatocytes","volume":"62","author":"Nakayama","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.phymed.2024.155379_bib0129","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1177\/0963689719851772","article-title":"Pancreatic stellate cells facilitate perineural invasion of pancreatic cancer via HGF\/c-Met pathway","volume":"28","author":"Nan","year":"2019","journal-title":"Cell Transplant."},{"key":"10.1016\/j.phymed.2024.155379_bib0130","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1593\/neo.09622","article-title":"Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells","volume":"11","author":"Navab","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.phymed.2024.155379_bib0131","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0168-8278(96)80006-7","article-title":"Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma","volume":"24","author":"Noguchi","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155379_bib0132","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1200\/jco.2013.31.4_suppl.294","article-title":"Phase I\/II study of E7050 (golvantinib) in combination with sorafenib in patients (pts) with advanced hepatocellular carcinoma (HCC): Phase I results","volume":"31","author":"O'Neil","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2024.155379_bib0133","first-page":"4177","article-title":"Curcumin inhibits epithelial-mesenchymal transition in oral cancer cells via c-Met blockade","volume":"19","author":"Ohnishi","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phymed.2024.155379_bib0134","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1158\/0008-5472.CAN-06-3339","article-title":"Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification","volume":"67","author":"Okabe","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0135","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fendo.2018.00503","article-title":"The Role of Hepatocyte Growth Factor (HGF) in Insulin Resistance and Diabetes","volume":"9","author":"Oliveira","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.phymed.2024.155379_bib0136","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.phymed.2024.155379_bib0137","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1440-1827.1998.tb03835.x","article-title":"c-Met expression of thyroid tissue with special reference to papillary carcinoma","volume":"48","author":"Oyama","year":"1998","journal-title":"Pathol. Int."},{"key":"10.1016\/j.phymed.2024.155379_bib0138","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.semcancer.2021.05.027","article-title":"A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma","volume":"86","author":"Pandya","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.phymed.2024.155379_bib0139","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0092-8674(86)90564-7","article-title":"Mechanism of met oncogene activation","volume":"45","author":"Park","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.155379_bib0140","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/carcin\/bgu122","article-title":"The role of the hepatocyte growth factor\/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer","volume":"35","author":"Patel","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phymed.2024.155379_bib0141","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1535-6108(03)00085-0","article-title":"Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene","volume":"3","author":"Pennacchietti","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2024.155379_bib0142","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1158\/1078-0432.CCR-06-0818","article-title":"Targeting the c-Met signaling pathway in cancer","volume":"12","author":"Peruzzi","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0143","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1097-2765(01)00378-1","article-title":"Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein","volume":"8","author":"Peschard","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2024.155379_bib0144","doi-asserted-by":"crossref","first-page":"9170","DOI":"10.3390\/ijms21239170","article-title":"Targeting HGF\/c-MET axis in pancreatic cancer","volume":"21","author":"Pothula","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2024.155379_bib0145","doi-asserted-by":"crossref","first-page":"e79101","DOI":"10.1371\/journal.pone.0079101","article-title":"Combination of the c-Met inhibitor tivantinib and zoledronic acid prevents tumor bone engraftment and inhibits progression of established bone metastases in a breast xenograft model","volume":"8","author":"Previdi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2024.155379_bib0146","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1158\/1078-0432.CCR-06-0776","article-title":"c-Met is a potentially new therapeutic target for treatment of human melanoma","volume":"13","author":"Puri","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0147","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.1158\/0008-5472.CAN-08-4889","article-title":"Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases","volume":"69","author":"Qian","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0148","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1158\/1078-0432.CCR-11-2830","article-title":"cMET and phospho-cMET protein levels in breast cancers and survival outcomes","volume":"18","author":"Raghav","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0149","first-page":"263","article-title":"Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma","volume":"7","author":"Rahimi","year":"1996","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.phymed.2024.155379_bib0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12943-022-01503-1","article-title":"Molecular mechanism(s) of regulation(s) of c-MET\/HGF signaling in head and neck cancer","volume":"21","author":"Raj","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0151","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102945","article-title":"A novel combination therapy with cabozantinib and honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress","volume":"68","author":"Rawat","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.phymed.2024.155379_bib0152","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1158\/1538-7445.AM2020-528","article-title":"Abstract 528: EMB-01: an innovative bispecific antibody targeting EGFR and cMet on tumor cells mediates a novel mechanism to improve anti-tumor efficacy","volume":"80","author":"Ren","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0153","first-page":"2019","article-title":"Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase","volume":"9","author":"Rodrigues","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155379_bib0154","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1101\/SQB.1994.059.01.072","article-title":"Autocrine mechanism for met proto-oncogene tumorigenicity","volume":"59","author":"Rong","year":"1994","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.phymed.2024.155379_bib0155","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/path.1522","article-title":"Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid","volume":"202","author":"Scarpino","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.phymed.2024.155379_bib0156","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phymed.2024.155379_bib0157","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0168-8278(05)80400-3","article-title":"Expression of hepatocyte growth factor mRNA, and c-met mRNA (hepatocyte growth factor receptor) in human liver tumours","volume":"21","author":"Selden","year":"1994","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155379_bib0158","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/sj.onc.1203404","article-title":"Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1","volume":"19","author":"Seol","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155379_bib0159","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1245\/s10434-007-9583-5","article-title":"Development and characterization of gemcitabine-resistant pancreatic tumor cells","volume":"14","author":"Shah","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.phymed.2024.155379_bib0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/01635581.2011.523502","article-title":"Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer","volume":"63","author":"Shanmugam","year":"2011","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0161","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.3390\/molecules20022728","article-title":"The multifaceted role of curcumin in cancer prevention and treatment","volume":"20","author":"Shanmugam","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2024.155379_bib0162","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/1570161115666170713094319","article-title":"Potential role of natural compounds as anti-angiogenic agents in cancer","volume":"15","author":"Shanmugam","year":"2017","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155379_bib0163","article-title":"Correlation between hypoxia and HGF\/c-MET expression in the management of pancreatic cancer","volume":"1878","author":"Sharma","year":"2023","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2024.155379_bib0164","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance","volume":"10","author":"Sharma","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-018-0839-4","article-title":"Met is involved in TIGAR-regulated metastasis of non-small-cell lung cancer","volume":"17","author":"Shen","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0166","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1002\/jcb.27972","article-title":"A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca(2+) \/calmodulin-dependent protein kinase II","volume":"120","author":"Shin","year":"2019","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.phymed.2024.155379_bib0167","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1479-5876-8-135","article-title":"Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer","volume":"8","author":"Simonetti","year":"2010","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phymed.2024.155379_bib0168","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1200\/JCO.2012.45.0494","article-title":"Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial","volume":"31","author":"Smith","year":"2013","journal-title":"J.Clin. Oncol."},{"key":"10.1016\/j.phymed.2024.155379_bib0169","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7150\/jca.9696","article-title":"cMET activation and EGFR-directed therapy resistance in triple-negative breast cancer","volume":"5","author":"Sohn","year":"2014","journal-title":"J. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0170","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1073\/pnas.88.11.4892","article-title":"The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions","volume":"88","author":"Soman","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phymed.2024.155379_bib0171","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/ph15050633","article-title":"Artonin F induces the ubiquitin-proteasomal degradation of c-Met and decreases Akt-mTOR signaling","volume":"15","author":"Soonnarong","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phymed.2024.155379_bib0172","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2613.2000.00138.x","article-title":"Hepatocyte growth factor\/scatter factor-induced intracellular signalling","volume":"81","author":"Stuart","year":"2000","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.phymed.2024.155379_bib0173","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1074\/jbc.M406714200","article-title":"Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma","volume":"280","author":"Suzuki","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2024.155379_bib0174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphs.2017.06.006","article-title":"Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt\/mTOR pathway","volume":"135","author":"Tang","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.phymed.2024.155379_bib0175","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/1097-0215(20000901)87:5<644::AID-IJC4>3.0.CO;2-W","article-title":"u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma","volume":"87","author":"Tavian","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0176","first-page":"187","article-title":"Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization","volume":"100","author":"Tong","year":"2004","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.phymed.2024.155379_bib0177","first-page":"225","article-title":"Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma","volume":"148","author":"Tuck","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phymed.2024.155379_bib0178","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1038\/s41467-021-24367-3","article-title":"Structural basis of the activation of c-MET receptor","volume":"12","author":"Uchikawa","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2024.155379_bib0179","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/hep.510250413","article-title":"Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma","volume":"25","author":"Ueki","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2024.155379_bib0180","doi-asserted-by":"crossref","first-page":"48342","DOI":"10.1074\/jbc.M209481200","article-title":"Autocrine activation of the hepatocyte growth factor receptor\/met tyrosine kinase induces tumor cell motility by regulating pseudopodial protrusion","volume":"277","author":"Vadnais","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2024.155379_bib0181","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1158\/1078-0432.CCR-15-0235","article-title":"Integrating murine and clinical trials with cabozantinib to understand roles of MET and VEGFR2 as targets for growth inhibition of prostate cancer","volume":"22","author":"Varkaris","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0182","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1038\/s41598-018-28672-8","article-title":"Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis","volume":"8","author":"Vsiansky","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2024.155379_bib0183","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcell.2020.00055","article-title":"The function of the HGF\/c-Met axis in hepatocellular carcinoma","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.phymed.2024.155379_bib0184","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/ijms20020384","article-title":"Targeting the hepatocyte growth factor and c-Met signaling axis in bone metastases","volume":"20","author":"Whang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2024.155379_bib0185","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.dld.2006.03.007","article-title":"The clinical value of hepatocyte growth factor and its receptor\u2013c-met for liver cancer patients with hepatectomy","volume":"38","author":"Wu","year":"2006","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.phymed.2024.155379_bib0186","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1158\/1078-0432.CCR-13-2620","article-title":"Cabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and MET","volume":"20","author":"Xiang","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0187","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1158\/0008-5472.CAN-15-3541","article-title":"Activation of the c-Met pathway mobilizes an inflammatory network in the brain microenvironment to promote brain metastasis of breast cancer","volume":"76","author":"Xing","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0188","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41416-020-0782-1","article-title":"Targeting the HGF\/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis","volume":"122","author":"Xu","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155379_bib0189","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ptr.5056","article-title":"Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells","volume":"28","author":"Yamauchi","year":"2014","journal-title":"Phytother Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yexcr.2018.07.041","article-title":"Paracrine HGF\/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP\/HIF-1\u03b1","volume":"371","author":"Yan","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0191","doi-asserted-by":"crossref","first-page":"8303","DOI":"10.3390\/ijms21218303","article-title":"Anti-neoplastic effect of ginkgolide C through modulating c-met phosphorylation in hepatocellular carcinoma cells","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2024.155379_bib0192","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/156652412798889063","article-title":"Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy","volume":"12","author":"Zhang","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.phymed.2024.155379_bib0193","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13046-018-0750-2","article-title":"The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma","volume":"37","author":"Zhang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155379_bib0194","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s10620-010-1416-x","article-title":"Expression and prognostic significance of CD151, c-Met, and integrin alpha3\/alpha6 in pancreatic ductal adenocarcinoma","volume":"56","author":"Zhu","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phymed.2024.155379_bib0195","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1007\/s13277-015-4187-3","article-title":"Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1","volume":"37","author":"Zhu","year":"2016","journal-title":"Tumour. Biol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324000448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324000448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T15:16:50Z","timestamp":1724080610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":193,"alternative-id":["S0944711324000448"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155379","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155379"}}